Flephedrone
From Wikipedia, the free encyclopedia
 | |
|---|---|
| Systematic (IUPAC) name | |
| (RS)-1-(4-fluorophenyl)-2-methylaminopropan-1-one | |
| Clinical data | |
| Legal status | Illegal in Czech Republic,[citation needed] Denmark,[citation needed] UK,[citation needed] Poland, some states within the US |
| Routes | Oral,insufflation,vaporized |
| Identifiers | |
| CAS number | 7589-35-7  |
| ATC code | ? |
| ChemSpider | 21477355 |
| Chemical data | |
| Formula | C10H12FNO |
| Mol. mass | 181.206 g/mol |
| SMILES
| |
| |
| (what is this?) (verify) | |
Flephedrone, also known as 4-fluoromethcathinone (4-FMC), is a stimulant drug of the cathinone chemical class.
History
Flephedrone started to be sold as a designer drug in 2008, along with its positional isomer 3-fluoromethcathinone (3-FMC).[1][2]
3-Fluoromethcathinone
Toxicity
Flephedrone has only a short history of human use and its toxicity is not well established.[3]
Legality
Flephedrone has been illegal in Denmark since December 2008.[citation needed]
Flephedrone has been illegal in the UK since April 2010.
Flephedrone has been illegal in the Lithuania since April 2010.
Flephedrone is most likely illegal in Australia as an analogue or derivative of cathinone.
Flephedrone has been illegal in Poland since April 2010,[4] but 3-FMC is still legal.
Flephedrone has been classed as a narcotic in Sweden since October 2010.[5]
Flephedrone has been listed since January 2011 as a Schedule I drug in Florida (United States).[6]
Flephedrone (4-Fluoromethcathinone) was classified as a schedule I controlled substance in Georgia (United States) in May 2011.
Flephedrone has been listed since June 2011 as a Schedule I drug in Pennsylvania (United States).[7]
See also
References
- ↑ Davies S. Drug Trends and New Designer Drugs. St George's University of London. 6th November 2008.
- ↑ Archer RP. Fluoromethcathinone, a new substance of abuse. Forensic Science International. 2009 Mar 10;185(1-3):10-20. PMID 19195800
- ↑ Thornton, S. L.; Gerona, R. R.; Tomaszewski, C. A. (2012). "Psychosis from a Bath Salt Product Containing Flephedrone and MDPV with Serum, Urine, and Product Quantification". Journal of Medical Toxicology 8 (3): 310–313. doi:10.1007/s13181-012-0232-4. PMC 3550171. PMID 22528592.
- ↑ "Ustawa z dnia 15 kwietnia 2011 r. o zmianie ustawy o przeciwdziałaniu narkomanii ( Dz.U. 2011 nr 105 poz. 614 )". Internetowy System Aktów Prawnych. Retrieved 17 June 2011.
- ↑ , Medical Products Agency (Sweden), Läkemedelsverkets författningssamling (Swedish)
- ↑ http://www.myfloridalicense.com/dbpr/abt/documents/BathSaltsDrugEmergencyRule.pdf
- ↑ http://www.legis.state.pa.us/cfdocs/legis/PN/Public/btCheck.cfm?txtType=HTM&sessYr=2011&sessInd=0&billBody=S&billTyp=B&billNbr=1006&pn=1304
| ||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.